Market Tracker

12/09 5:16pm ET

Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC)

4.00
Delayed Data
As of Dec 09
 -0.12 / -2.91%
Today’s Change
3.05
Today|||52-Week Range
9.72
-33.33%
Year-to-Date
No recent news for Cyclacel Pharmaceuticals Inc.

Today’s Trading

Previous close4.12
Today’s open4.10
Day’s range4.00 - 4.30
Volume66,225
Average volume (3 months)343,092
Market cap$17.0M
Dividend yield--
Data as of 4:00pm ET, 12/09/2016

Growth & Valuation

Earnings growth (last year)+49.44%
Earnings growth (this year)+27.96%
Earnings growth (next 5 years)--
Revenue growth (last year)+12.11%
P/E ratioNM
Price/Sales8.37
Price/Book0.63

Competitors

 Today’s
change
Today’s
% change
ONTXOnconova Therapeutic...-0.15-5.66%
EYEGEyeGate Pharmaceutic...+0.11+6.83%
BLPHBellerophon Therapeu...+0.05+10.23%
CBLICleveland Biolabs In...+0.01+0.63%
Data as of 4:00pm ET, 12/09/2016

Financials

Next reporting dateMarch 29, 2017
EPS forecast (this quarter)-$0.89
Annual revenue (last year)$1.9M
Annual profit (last year)-$14.3M
Net profit margin-737.76%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Spiro Rombotis
COO, CFO, Secretary, Director &
Executive VP
Paul McBarron
Corporate headquarters
Berkeley Heights, New Jersey

Forecasts